Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

With Deadline Looming, Novartis Yet To Reach Fee-For-Service Contracts

This article was originally published in The Pink Sheet Daily

Executive Summary

Novartis has not entered into fee-for-service contracts with any of its distributors, Novartis Pharmaceuticals CEO Paolo Costa said March 15

You may also be interested in...



McKesson Fee-For-Service Negotiations Encounter A Handful Of Holdouts

Approximately four of McKesson’s “larger manufacturer” partners have not reached, and are not in talks on, fee-for-service contracts. McKesson will not necessarily drop manufacturers that do not reach a formal agreement as long as the economics continue to work, CEO Hammergren says.

Pfizer Says No To "Fee-For-Service" Contracts With Wholesalers

The manufacturer maintains that wholesalers "purchase and resell products for their own account and not as a service to Pfizer." Cardinal will no longer distribute Eisai products, including the Alzheimer's drug Aricept, marketed in partnership with Pfizer.

Cardinal Fee-For-Service Ultimatum Has “Accelerated” Contracting, CEO Says

Cardinal's progress in signing fee-for-service distribution contracts with pharmaceutical manufacturers has "accelerated" since the wholesaler set a March 31 contract deadline

Topics

UsernamePublicRestriction

Register

PS061747

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel